Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-12

Clinical Trial Update: Ipratropium Bromide in Peri-Operative COPD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ipratropium bromide in peri-operative COPD has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2016-09-12